NARCAN (Adapt Pharma, Inc.)
Welcome to the PulseAid listing for the NARCAN drug offered from Adapt Pharma, Inc.. This Opioid Antagonist [EPC],Opioid Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Adapt Pharma, Inc. |
NON-PROPRIETARY NAME: | naloxone hydrochloride |
SUBSTANCE NAME: | NALOXONE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Opioid Antagonist [EPC],Opioid Antagonists [MoA] |
ROUTE: | NASAL |
DOSAGE FORM: | SPRAY |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2017-01-24 |
END MARKETING DATE: | 0000-00-00 |
NARCAN HUMAN PRESCRIPTION DRUG Details:
Item Description | NARCAN from Adapt Pharma, Inc. |
LABELER NAME: | Adapt Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2(mg/.1mL) |
START MARKETING DATE: | 2017-01-24 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69547-212_93266116-8de4-45ed-8e93-323db00b211f |
PRODUCT NDC: | 69547-212 |
APPLICATION NUMBER: | NDA208411 |
Other NALOXONE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: